In this study, we performed genetic analysis of peripheral blood from this endometrial cancer patient with MLH1 and PMS2 protein losses using IHC despite MLH1 promoter hypermethylation because Lynch syndrome was suspected based on family history and clinical factors. The gene discussed is PMS2; the disease is endometrial cancer.